Yumanity Therapeutics Inc to Discuss the Proposed Merger with Kineta Inc - Conference Call Transcript
Good morning, and welcome to the Yumanity Therapeutics, Kineta, Inc. Conference Call. Earlier this morning, Yumanity announced definitive agreements for 2 strategic transactions with Janssen Pharmaceutica NV and Kineta, Inc.. This press release can be found on the Yumanity website at www.yumanity.com.
Please note, there are slides accompanying this call, which are viewable in the webcast player. A PDF of the webcast slides will also be made available on the company's website. Joining me on the call this morning are Dr. Richard Peters, Chief Executive Officer of Yumanity Therapeutics; and Dr. Shawn Iadonato, Chief Executive Officer of Kineta.
Turning to Slide 2. Please note that today's conference call will contain statements about future expectations and plans that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995.
The words believe, anticipate, plan, potential, expect and other words future events identify statements as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |